TABLE 1.
Baseline lipid data following background statin (panel A) or placebo (panel B) treatment
| Characteristic | Panel A (N = 29) | Panel B (N = 10) | All Subjects (N = 39) |
| TC (mg/dl) | 163 | 209 | 184 |
| Geometric mean (% CV) | (13) | (17) | (17) |
| TGs (mg/dl) | 89 | 121 | 104 |
| Geometric mean (% CV) | (38) | (59) | (44) |
| LDL-C (mg/dl) | 90 | 134 | 93 |
| Median (IQR) | (16) | (23) | (39) |
| HDL-C (mg/dl) | 48 | 43 | 48 |
| Median (IQR) | (19) | (20) | (20) |
| apoC-II (mg/dl) | 4.4 | 5.2 | 4.4 |
| Median (IQR) | (1.3) | (3.1) | (1.5) |
| apoC-III (mg/dl) | 7.4 | 8.4 | 7.9 |
| Geometric mean (% CV) | (40.8) | (35.2) | (39.4) |
| apoE (mg/dl) | 3.3 | 4.4 | 3.7 |
| Median (IQR) | (0.8) | (0.8) | (0.8) |